{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:23:52Z","timestamp":1787235832233,"version":"build-2736575974"},"reference-count":68,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background and Aims: Vitamin D is currently well regarded for its pleiotropic effects on the immune system, stimulating an anti-inflammatory response and enhancing immune tolerance. Vitamin D deficiency is an established risk factor for multiple sclerosis (MS). Additionally, lower vitamin D serum levels are associated with worse disease outcomes. However, current randomized clinical trials provide conflicting evidence about the beneficial role of vitamin D on disease progression. Most studies have evaluated the effect of vitamin D supplementation on clinical and radiological activity, yet very few have examined the impact on brain atrophy. Methods: A 4-year observational, non-interventional study design was applied to evaluate the association between vitamin D supplementation and disease progression. Altogether, 132 relapsing\u2013remitting multiple sclerosis patients were enrolled in the study (97 subjects in the group with vitamin D supplementation and 35 subjects in the group without supplementation). The analyzed groups were similar in terms of age, body mass index, sun exposure, comorbidities, nicotinism, duration of the disease, and current treatment. The number of relapses, Expanded Disability Status Scale assessments, and the number of new\/enlarged T2-weighted lesions and gadolinium-enhancing lesions in magnetic resonance imagining analyses, as well as 25-hydroxyvitamin D serum levels, were assessed every 12 months of a 4-year follow-up, whereas brain atrophy was assessed at the baseline and after 36 months using two-dimensional measurements. Results: After 36 months, a significant increase in atrophy was observed in both groups; however, patients without vitamin D supplementation had a significantly higher increase in intercaudate distance, third ventricle width, and bicaudate ratio after 36 months of observation (p &lt; 0.05). Vitamin D supplementation among the studied group did not affect other disease activity outcomes. Conclusions: Our study revealed an observed association between vitamin D supplementation and reduced brain atrophy in patients with MS. Randomized controlled trials are required to establish the impact of vitamin D supplementation on brain atrophy progression.<\/jats:p>","DOI":"10.3390\/nu17142271","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:38:27Z","timestamp":1752140307000},"page":"2271","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Does Vitamin D Supplementation Slow Brain Volume Loss in Multiple Sclerosis? A 4-Year Observational Study"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-7013","authenticated-orcid":false,"given":"Weronika","family":"Galus","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-5660","authenticated-orcid":false,"given":"Mateusz","family":"Winder","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-6932","authenticated-orcid":false,"given":"Aleksander J.","family":"Owczarek","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Walawska-Hrycek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalina","family":"Rzepka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kaczmarczyk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-660X","authenticated-orcid":false,"given":"Joanna","family":"Siuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-3088","authenticated-orcid":false,"given":"Ewa","family":"Krzystanek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000486536","article-title":"Vitamin D: Classic and Novel Actions","volume":"72","author":"Gil","year":"2018","journal-title":"Ann. Nutr. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-013-8361-3","article-title":"The implication of vitamin D and autoimmunity: A comprehensive review","volume":"45","author":"Yang","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.11.015","article-title":"Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis","volume":"184","author":"Peterson","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of Multiple Sclerosis: A Review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"a028928","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical Course of Multiple Sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5603\/pjnns.98592","article-title":"Clinical and therapeutic challenges of smouldering multiple sclerosis","volume":"58","author":"Niedziela","year":"2024","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13317-019-0117-5","article-title":"Brain atrophy in multiple sclerosis: Mechanisms, clinical relevance and treatment options","volume":"10","author":"Andravizou","year":"2019","journal-title":"Autoimmun. Highlights"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00234-020-02401-3","article-title":"A validation study of manual atrophy measures in patients with Multiple Sclerosis","volume":"62","author":"Cappelle","year":"2020","journal-title":"Neuroradiology"},{"key":"ref_11","first-page":"433","article-title":"Quantification of brain atrophy in multiple sclerosis using two-dimensional measurements","volume":"35","year":"2020","journal-title":"Neurolog\u00eda"},{"key":"ref_12","first-page":"20552173211070749","article-title":"Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis","volume":"8","author":"Ajitomi","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0036-1579693","article-title":"Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention\u2014An Update","volume":"36","author":"Ascherio","year":"2016","journal-title":"Semin. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1212\/NXG.0000000000000097","article-title":"Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk","volume":"2","author":"Rhead","year":"2016","journal-title":"Neurol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jiang, X., Ge, T., and Chen, C.Y. (2021). The causal role of circulating vitamin D concentrations in human complex traits and diseases: A large-scale Mendelian randomization study. Sci. Rep., 11.","DOI":"10.1038\/s41598-020-80655-w"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"fcac171","DOI":"10.1093\/braincomms\/fcac171","article-title":"Full spectrum of vitamin D immunomodulation in multiple sclerosis: Mechanisms and therapeutic implications","volume":"4","author":"Galoppin","year":"2022","journal-title":"Brain Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of Vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sangha, A., Quon, M., Pfeffer, G., and Orton, S.M. (2023). The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update. Nutrients, 15.","DOI":"10.3390\/nu15132978"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sparaco, M., and Bonavita, S. (2024). Vitamin D Supplementation: Effect on Cytokine Profile in Multiple Sclerosis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030835"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Walawska-Hrycek, A., Galus, W., Hrycek, E., Kaczmarczyk, A., and Krzystanek, E. (2021). The Impact of Vitamin D Low Doses on Its Serum Level and Cytokine Profile in Multiple Sclerosis Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132781"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116668","DOI":"10.1016\/j.jns.2020.116668","article-title":"Associations of serum 25(OH) vitamin D levels with clinical and radiological outcomes in multiple sclerosis: A systematic review and meta-analysis","volume":"411","author":"Mahatanan","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3934\/Neuroscience.2021013","article-title":"Vitamin D status and disability among patients with multiple sclerosis: A systematic review and meta-analysis","volume":"8","author":"Moosazadeh","year":"2021","journal-title":"AIMS Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000515131","article-title":"The Effect of Different Administration Time and Dosage of Vitamin D Supplementation in Patients with Multiple Sclerosis: A Meta-Analysis of Randomized Controlled Trials","volume":"28","author":"Yuan","year":"2021","journal-title":"Neuroimmunomodulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/ijpvm.IJPVM_208_20","article-title":"Effect of Vitamin D Supplements on Relapse Rate and Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis","volume":"12","author":"Hanaei","year":"2021","journal-title":"Int. J. Prev. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.05.008","article-title":"The efficacy of vitamin D in multiple sclerosis: A meta-analysis","volume":"23","author":"Zheng","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105564","DOI":"10.1016\/j.clineuro.2019.105564","article-title":"The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and meta-analysis of randomized controlled trials","volume":"187","author":"Tamtaji","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_29","first-page":"CD008422","article-title":"Vitamin D for the management of multiple sclerosis","volume":"9","author":"Jagannath","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00415-018-9074-6","article-title":"Vitamin D for the treatment of multiple sclerosis: A meta-analysis","volume":"265","author":"McLaughlin","year":"2018","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105433","DOI":"10.1016\/j.msard.2024.105433","article-title":"Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Mahler","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.26444\/aaem\/127062","article-title":"Correlation between vitamin D and alterations in MRI among patients with multiple sclerosis","volume":"28","author":"Rocka","year":"2021","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e15754","DOI":"10.1016\/j.heliyon.2023.e15754","article-title":"Association between vitamin D deficiency and multiple sclerosis\u2014MRI significance: A scoping review","volume":"9","author":"Hajeer","year":"2023","journal-title":"Heliyon"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Rusi\u0144ska, A., P\u0142udowski, P., Walczak, M., Borszewska-Kornacka, M.K., Bossowski, A., Chlebna-Sok\u00f3\u0142, D., Czech-Kowalska, J., Dobrza\u0144ska, A., Franek, E., and Helwich, E. (2018). Vitamin D supplementation guidelines for the general population and groups at risk of vitamin D deficiency in Poland\u2014Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00246"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archneurpsyc.1942.02290060069004","article-title":"An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy","volume":"47","author":"Evans","year":"1942","journal-title":"Arch. Neuropsychol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbiomolbio.2006.02.017","article-title":"Vitamin D in foods and as supplements","volume":"92","year":"2006","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add-on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Elovaara","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1212\/NXI.0000000000000597","article-title":"Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)","volume":"6","author":"Camu","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","article-title":"A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis","volume":"77","author":"Stein","year":"2011","journal-title":"Neurology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","article-title":"Therapeutic effect of vitamin D3 in multiple sclerosis patients","volume":"40","author":"Mosayebi","year":"2011","journal-title":"Immunol. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Galus, W., Chmiela, T., Walawska-Hrycek, A., and Krzystanek, E. (2023). Radiological Benefits of Vitamin D Status and Supplementation in Patients with MS\u2014A Two-Year Prospective Observational Cohort Study. Nutrients, 15.","DOI":"10.3390\/nu15061465"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22043","article-title":"Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis","volume":"68","author":"Simpson","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_46","first-page":"2055217320903474","article-title":"High-dose vitamin D supplementation in multiple sclerosis\u2014Results from the randomized EVIDIMS trial","volume":"6","author":"Wernecke","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp-2024-334062","article-title":"Vitamin D affects the risk of disease activity in multiple sclerosis","volume":"96","author":"Giordano","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: Time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.0b013e3181e24136","article-title":"Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes","volume":"74","author":"Giorgio","year":"2010","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104714","DOI":"10.1016\/j.msard.2023.104714","article-title":"The association between brain volume loss and disability in multiple sclerosis: A systematic review","volume":"74","author":"Matthews","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Guenter, W., Betscher, E., and Bonek, R. (2022). Predictive value of the third ventricle width for neurological status in multiple sclerosis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102841"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archneur.61.2.226","article-title":"Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional MRI measures of atrophy and lesion burden","volume":"61","author":"Benedict","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2010.227942","article-title":"Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients","volume":"82","author":"Zivadinov","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jamaneurol.2015.2742","article-title":"Association of Vitamin D Levels with Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b","volume":"72","author":"Fitzgerald","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/apm.12281","article-title":"Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model","volume":"122","author":"Nystad","year":"2014","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wergeland, S., Torkildsen, \u00d8., Myhr, K.-M., Aksnes, L., M\u00f8rk, S.J., B\u00f8, L., and Reindl, M. (2011). Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026262"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.celrep.2017.08.007","article-title":"Pericytes stimulate oligodendrocyte progenitor cell differentiation during CNS remyelination","volume":"20","author":"Lange","year":"2017","journal-title":"Cell Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO;2-Y","article-title":"Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3)","volume":"31","author":"Baas","year":"2000","journal-title":"Glia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yexmp.2015.02.004","article-title":"1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation","volume":"98","author":"Shirazi","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1002\/fsn3.2382","article-title":"Association of 25-hydroxyvitamin D status with brain volume changes","volume":"9","author":"Lee","year":"2021","journal-title":"Food Sci. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Xu, Y., Wang, E., Zhang, Q., Liu, J., and Luo, W. (2024). Vitamin D and Focal Brain Atrophy in PD with Non-Dementia: A VBM Study. Front. Hum. Neurosci., 18.","DOI":"10.3389\/fnhum.2024.1474148"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Boccardi, V., Comanducci, C., Baroni, M., and Mecocci, P. (2017). Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122672"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.msard.2019.02.007","article-title":"Time between expanded disability status scale (EDSS) scores","volume":"30","author":"Zurawski","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/CPJ.0000000000001045","article-title":"Multiple sclerosis phenotypes as a continuum: The role of neurologic reserve","volume":"11","author":"Vollmer","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.abb.2006.12.017","article-title":"Factors that influence the cutaneous synthesis and dietary sources of vitamin D","volume":"460","author":"Chen","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e16269","DOI":"10.1111\/ene.16269","article-title":"Association between sun exposure habits and disease progression in multiple sclerosis","volume":"31","author":"Wu","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"P\u0142udowski, P., Kos-Kud\u0142a, B., Walczak, M., Fal, A., Zozuli\u0144ska-Zi\u00f3\u0142kiewicz, D., Sieroszewski, P., Peregud-Pogorzelski, J., Lauterbach, R., Targowski, T., and Lewi\u0144ski, A. (2023). Guidelines for preventing and treating vitamin D deficiency: A 2023 update in Poland. Nutrients, 15.","DOI":"10.3390\/nu15030695"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/14\/2271\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:07:12Z","timestamp":1760033232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/14\/2271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":68,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["nu17142271"],"URL":"https:\/\/doi.org\/10.3390\/nu17142271","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}